BBIO
BridgeBio Pharma, Inc. Common Stock
$79.93
0.07%
+0.05
Notify me if price changes either direction
Buy BBIO stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
14.9B
Enterprise value
16.2B
Trailing PE
-27.038195398119
Forward PE
-44.255726
PEG Ratio
-2.5836497824869
Enterprise to EBITDA
-28.3
Enterprise to revenue
45.844
Price to book MRQ
-7.77004109429
Price to sales TTM
42.509148
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
353.8M
EBITDA
-573100992
Diluted EPS TTM
-4.21
Total Cash (MRQ)
645.9M
Current ratio (MRQ)
3.875
Operating Cash Flow (TTM)
-584816000
BBIO trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
